Shanghai Pharmaceuticals Holding Co. Ltd. (“SPH”) is a vertically-integrated and diversified Pharmaceutical group. The company has dual listings on the Stock Exchanges in Shanghai (601607) and Hong Kong (02067). The company is involved in research & development, manufacturing, distribution and retailing. Shanghai Pharma (Thailand) Co., Ltd. is the Marketing Authorization Holder and importer for SPH Products and Beyond. Including generics, biosimilars, original drugs, traditional Chinese medicines, healthcare products, and medical devices.
